Immuneering management plans to attend upcoming investor conferences
Immuneering Corporation (IMRX) said management plans to participate in upcoming investor conferences, with further details to follow.
NEW YORK, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation NASDAQ:IMRX, a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management plans to participate in the following upcoming investor conferences:Cantor Globa…